Compounds > triazoles
Page last updated: 2024-08-24

triazoles and zithromax

triazoles has been researched along with zithromax in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (5.56)29.6817
2010's14 (77.78)24.3611
2020's3 (16.67)2.80

Authors

AuthorsStudies
Ghahramani, P; Kleinermans, D; Layton, G; Nichols, D; Purkins, L; Wood, N1
Castanheira, M; Jones, RN; Woosley, LN1
Biedenbach, DJ; Castanheira, M; Jones, RN1
Arafat, T; Idkaidek, N1
Fernandes, P; Guyard, C; Mallegol, J; Melano, RG1
Fernandes, P; Jensen, JS; Unemo, M1
Carter, S; Jobe, AH; Kallapur, SG; Keelan, JA; Kemp, MW; Miura, Y; Newnham, JP; Noe, A; Payne, MS; Saito, M; Spiller, OB; Stock, SJ; Watts, R1
Furfaro, LL; Keelan, JA; Payne, MS; Spiller, OB1
Cetina, M; Kraljević, TG; Maračić, S; Matijašić, M; Paljetak, HČ; Perić, M; Raić-Malić, S; Verbanac, D1
Chong, Y; Lee, H; Lee, K1
Farrell, DJ; Flamm, RK; Jones, RN; Sader, HS1
Colon, BL; Guy, RK; Kyle, DE; Rice, CA1
de Vries, HJC; Schim-van der Loeff, MF1
Avery, A; Bradshaw, CS; Chen, MY; Das, AF; Donovan, B; Fairley, CK; Hardy, D; Hocking, JS; Howden, BP; McNulty, A; Nenninger, A; Oldach, D; Tabrizi, SN; Whiley, D1
Craft, JC; Fernandes, P1
Aguado, JM; Andrés, A; Caravaca-Fontán, F; Fernández-Ruiz, M; Gutiérrez, E; López-Medrano, F; Morales, E; Praga, M; Sevillano, Á; Trujillo, H1
Ma, P; Qin, Y; Teng, Y; Wang, Y; Xu, L; Yang, Y1
Ma, P; Qin, Y; Sun, M; Yang, Y; Zhang, N1

Reviews

2 review(s) available for triazoles and zithromax

ArticleYear
New treatment options for infections caused by increasingly antimicrobial-resistant Neisseria gonorrhoeae.
    Expert review of anti-infective therapy, 2016, Volume: 14, Issue:2

    Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Ceftriaxone; Drug Resistance, Bacterial; Drug Therapy, Combination; Gonorrhea; Humans; Isoxazoles; Macrolides; Morpholines; Neisseria gonorrhoeae; Neisseriaceae Infections; Oxazolidinones; Pharyngitis; Spectinomycin; Spiro Compounds; Triazoles

2016
Invasive pulmonary aspergillosis associated with COVID-19 in a kidney transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2021, Volume: 23, Issue:2

    Topics: Acute Kidney Injury; Administration, Inhalation; Amphotericin B; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antifungal Agents; Azithromycin; Ceftriaxone; COVID-19; Deprescriptions; Female; Glucocorticoids; Graft Rejection; Humans; Hydroxychloroquine; Hyperoxaluria, Primary; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Nitriles; Oxygen Inhalation Therapy; Prednisone; Pyridines; Renal Dialysis; SARS-CoV-2; Sputum; Tacrolimus; Tomography, X-Ray Computed; Triazoles

2021

Trials

2 trial(s) available for triazoles and zithromax

ArticleYear
No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers.
    British journal of clinical pharmacology, 2003, Volume: 56 Suppl 1

    Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Area Under Curve; Azithromycin; Drug Combinations; Drug Interactions; Erythromycin; Humans; Male; Pyrimidines; Triazoles; Voriconazole

2003
Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial.
    The Lancet. Infectious diseases, 2019, Volume: 19, Issue:8

    Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Female; Gonorrhea; Humans; Injections, Intramuscular; Macrolides; Male; Neisseria gonorrhoeae; Treatment Outcome; Triazoles; United States

2019

Other Studies

14 other study(ies) available for triazoles and zithromax

ArticleYear
CEM-101 activity against Gram-positive organisms.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Gentamicins; Gram-Positive Bacteria; Ketolides; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin

2010
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Minocycline; Neisseria meningitidis; Penicillins; Rifampin; Sulfamethoxazole; Triazoles; Trimethoprim

2010
Saliva versus plasma pharmacokinetics: theory and application of a salivary excretion classification system.
    Molecular pharmaceutics, 2012, Aug-06, Volume: 9, Issue:8

    Topics: Acetates; Anthraquinones; Azithromycin; Benzhydryl Compounds; Cinacalcet; Cloxacillin; Cresols; Cyclopropanes; Female; Fluorobenzenes; Humans; Hydrochlorothiazide; Losartan; Male; Metformin; Naphthalenes; Phenylpropanolamine; Piroxicam; Pyrazines; Pyrimidines; Quinolines; Rosuvastatin Calcium; Saliva; Sitagliptin Phosphate; Sulfides; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Triazoles

2012
Antimicrobial activity of solithromycin against clinical isolates of Legionella pneumophila serogroup 1.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2

    Topics: Anti-Bacterial Agents; Azithromycin; Cell Line, Tumor; Clinical Trials, Phase III as Topic; Epithelial Cells; Humans; Legionella pneumophila; Legionnaires' Disease; Macrolides; Microbial Sensitivity Tests; Serotyping; Triazoles

2014
In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

    Topics: Anti-Bacterial Agents; Azithromycin; DNA, Bacterial; DNA, Ribosomal; Doxycycline; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycoplasma genitalium; Mycoplasma Infections; Neisseria gonorrhoeae; Triazoles

2014
Maternal intravenous treatment with either azithromycin or solithromycin clears Ureaplasma parvum from the amniotic fluid in an ovine model of intrauterine infection.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9

    Topics: Administration, Intravenous; Amniotic Fluid; Animals; Anti-Bacterial Agents; Azithromycin; Chemokine CCL2; Chemokine CCL8; Female; Fetus; Interleukins; Lung; Macrolides; Pneumonia; Pregnancy; Pregnancy Complications, Infectious; Sheep; Triazoles; Ureaplasma; Ureaplasma Infections

2014
In vitro activity of solithromycin and its metabolites, CEM-214 and N-acetyl-CEM-101, against 100 clinical Ureaplasma spp. isolates compared with azithromycin.
    International journal of antimicrobial agents, 2015, Volume: 46, Issue:3

    Topics: Anti-Bacterial Agents; Australia; Azithromycin; Drug Resistance, Bacterial; Female; Humans; Infant, Newborn; Macrolides; Microbial Sensitivity Tests; Pregnancy; Triazoles; United Kingdom; Ureaplasma; Ureaplasma Infections

2015
1,2,3-Triazole pharmacophore-based benzofused nitrogen/sulfur heterocycles with potential anti-Moraxella catarrhalis activity.
    Bioorganic & medicinal chemistry, 2015, Dec-01, Volume: 23, Issue:23

    Topics: Anti-Bacterial Agents; Azithromycin; Benzothiazoles; Click Chemistry; Heterocyclic Compounds, 2-Ring; Hydrophobic and Hydrophilic Interactions; Moraxella catarrhalis; Structure-Activity Relationship; Triazoles; Umbelliferones

2015
Results from the Solithromycin International Surveillance Program (2014).
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Anti-Bacterial Agents; Asia; Azithromycin; Bacterial Infections; Community-Acquired Infections; Epidemiological Monitoring; Europe; Haemophilus influenzae; Humans; International Cooperation; Ketolides; Latin America; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae; Triazoles; United States

2016
Phenotypic Screens Reveal Posaconazole as a Rapidly Acting Amebicidal Combination Partner for Treatment of Primary Amoebic Meningoencephalitis.
    The Journal of infectious diseases, 2019, 03-15, Volume: 219, Issue:7

    Topics: Amphotericin B; Animals; Antiprotozoal Agents; Azithromycin; Central Nervous System Protozoal Infections; Disease Models, Animal; Drug Combinations; Drug Discovery; Drug Synergism; Female; Fluconazole; Humans; Inhibitory Concentration 50; Mice; Naegleria fowleri; Phenotype; Time Factors; Triazoles; United States; United States Food and Drug Administration

2019
Solithromycin for the treatment of drug-resistant gonorrhoea.
    The Lancet. Infectious diseases, 2019, Volume: 19, Issue:8

    Topics: Azithromycin; Ceftriaxone; Genitalia; Gonorrhea; Humans; Macrolides; Triazoles

2019
Phase 3 trial of treating gonorrhoea with solithromycin.
    The Lancet. Infectious diseases, 2019, Volume: 19, Issue:9

    Topics: Azithromycin; Ceftriaxone; Genitalia; Gonorrhea; Humans; Macrolides; Triazoles

2019
Design, synthesis and antibacterial evaluation of novel 3-O-substituted 15-membered azalides possessing 1,2,3-triazole side chains.
    Bioorganic & medicinal chemistry letters, 2021, 10-01, Volume: 49

    Topics: Anti-Bacterial Agents; Azithromycin; Bacteria; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Ribosomes; Structure-Activity Relationship; Triazoles

2021
Synthesis and biological evaluation of antibacterial activity of novel clarithromycin derivatives incorporating 1,2,3-triazole moieties at the 4''- and 11-OH positions.
    Bioorganic chemistry, 2022, Volume: 127

    Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Triazoles

2022